ID   RRP5_HUMAN              Reviewed;        1871 AA.
AC   Q14690; Q2TA92; Q5W093; Q6P2J3; Q86VQ8; Q9H4P1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   28-JUN-2023, entry version 202.
DE   RecName: Full=Protein RRP5 homolog;
DE   AltName: Full=NF-kappa-B-binding protein;
DE            Short=NFBP;
DE   AltName: Full=Programmed cell death protein 11;
GN   Name=PDCD11; Synonyms=KIAA0185;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PHE-1216.
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V. The
RT   coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1442, AND VARIANT PHE-1216.
RC   TISSUE=Lymphoma, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-10 AND 1343-1352, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Mammary carcinoma;
RA   Bienvenut W.V., Matallanas D., Kolch W.;
RL   Submitted (JUL-2009) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1508-1871, AND VARIANT ALA-1871.
RC   TISSUE=Brain;
RA   Zhou J., Yu W., Tang H., Mei G., Tsang Y.T.M., Bouck J., Gibbs R.A.,
RA   Margolin J.F.;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [8]
RP   INTERACTION WITH NFKB1 AND RELA, AND SUBCELLULAR LOCATION.
RX   PubMed=14624448; DOI=10.1002/jcb.10701;
RA   Sweet T., Khalili K., Sawaya B.E., Amini S.;
RT   "Identification of a novel protein from glial cells based on its ability to
RT   interact with NF-kappaB subunits.";
RL   J. Cell. Biochem. 90:884-891(2003).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17654514; DOI=10.1002/jcp.21204;
RA   Sweet T., Yen W., Khalili K., Amini S.;
RT   "Evidence for involvement of NFBP in processing of ribosomal RNA.";
RL   J. Cell. Physiol. 214:381-388(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1498, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1493 AND SER-1498, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1360 AND SER-1362, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-438 AND SER-1498, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1030, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1416, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [21]
RP   STRUCTURE BY NMR OF 173-278.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the S1 RNA binding domain from human hypothetical
RT   protein BAA11502.";
RL   Submitted (NOV-2004) to the PDB data bank.
RN   [22]
RP   VARIANT GLU-45.
RX   PubMed=26566883; DOI=10.1136/jmedgenet-2015-103179;
RA   Rafiullah R., Aslamkhan M., Paramasivam N., Thiel C., Mustafa G.,
RA   Wiemann S., Schlesner M., Wade R.C., Rappold G.A., Berkel S.;
RT   "Homozygous missense mutation in the LMAN2L gene segregates with
RT   intellectual disability in a large consanguineous Pakistani family.";
RL   J. Med. Genet. 53:138-144(2016).
CC   -!- FUNCTION: Essential for the generation of mature 18S rRNA, specifically
CC       necessary for cleavages at sites A0, 1 and 2 of the 47S precursor.
CC       Directly interacts with U3 snoRNA. {ECO:0000269|PubMed:17654514}.
CC   -!- FUNCTION: Involved in the biogenesis of rRNA. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with NF-kappa-B p50/NFKB1 and NF-kappa-B p65/RELA.
CC       {ECO:0000269|PubMed:14624448}.
CC   -!- INTERACTION:
CC       Q14690; P19838: NFKB1; NbExp=2; IntAct=EBI-300028, EBI-300010;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849,
CC       ECO:0000269|PubMed:14624448, ECO:0000269|PubMed:17654514}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG01992.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC       Sequence=AAH49838.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH64486.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH80560.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAI11041.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA11502.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA11502.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D80007; BAA11502.1; ALT_INIT; mRNA.
DR   EMBL; AL139339; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591408; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL603983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49641.1; -; Genomic_DNA.
DR   EMBL; BC049838; AAH49838.1; ALT_SEQ; mRNA.
DR   EMBL; BC064486; AAH64486.1; ALT_SEQ; mRNA.
DR   EMBL; BC080560; AAH80560.1; ALT_SEQ; mRNA.
DR   EMBL; BC111040; AAI11041.1; ALT_SEQ; mRNA.
DR   EMBL; AY007124; AAG01992.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS31276.1; -.
DR   RefSeq; NP_055791.1; NM_014976.1.
DR   RefSeq; XP_011537841.1; XM_011539539.2.
DR   PDB; 1WI5; NMR; -; A=173-278.
DR   PDBsum; 1WI5; -.
DR   AlphaFoldDB; Q14690; -.
DR   SMR; Q14690; -.
DR   BioGRID; 116633; 389.
DR   IntAct; Q14690; 79.
DR   MINT; Q14690; -.
DR   STRING; 9606.ENSP00000358812; -.
DR   GlyGen; Q14690; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q14690; -.
DR   PhosphoSitePlus; Q14690; -.
DR   SwissPalm; Q14690; -.
DR   BioMuta; PDCD11; -.
DR   DMDM; 145559523; -.
DR   SWISS-2DPAGE; Q14690; -.
DR   CPTAC; CPTAC-1635; -.
DR   EPD; Q14690; -.
DR   jPOST; Q14690; -.
DR   MassIVE; Q14690; -.
DR   MaxQB; Q14690; -.
DR   PaxDb; Q14690; -.
DR   PeptideAtlas; Q14690; -.
DR   ProteomicsDB; 60128; -.
DR   Antibodypedia; 31534; 47 antibodies from 16 providers.
DR   DNASU; 22984; -.
DR   Ensembl; ENST00000369797.8; ENSP00000358812.3; ENSG00000148843.15.
DR   GeneID; 22984; -.
DR   KEGG; hsa:22984; -.
DR   MANE-Select; ENST00000369797.8; ENSP00000358812.3; NM_014976.2; NP_055791.1.
DR   UCSC; uc001kwy.2; human.
DR   AGR; HGNC:13408; -.
DR   CTD; 22984; -.
DR   DisGeNET; 22984; -.
DR   GeneCards; PDCD11; -.
DR   HGNC; HGNC:13408; PDCD11.
DR   HPA; ENSG00000148843; Low tissue specificity.
DR   MIM; 612333; gene.
DR   neXtProt; NX_Q14690; -.
DR   OpenTargets; ENSG00000148843; -.
DR   PharmGKB; PA134909758; -.
DR   VEuPathDB; HostDB:ENSG00000148843; -.
DR   eggNOG; KOG1070; Eukaryota.
DR   GeneTree; ENSGT00390000012228; -.
DR   HOGENOM; CLU_000845_1_1_1; -.
DR   InParanoid; Q14690; -.
DR   OrthoDB; 167902at2759; -.
DR   PhylomeDB; Q14690; -.
DR   TreeFam; TF105697; -.
DR   PathwayCommons; Q14690; -.
DR   Reactome; R-HSA-6790901; rRNA modification in the nucleus and cytosol.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   SignaLink; Q14690; -.
DR   BioGRID-ORCS; 22984; 749 hits in 1165 CRISPR screens.
DR   ChiTaRS; PDCD11; human.
DR   EvolutionaryTrace; Q14690; -.
DR   GenomeRNAi; 22984; -.
DR   Pharos; Q14690; Tbio.
DR   PRO; PR:Q14690; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q14690; protein.
DR   Bgee; ENSG00000148843; Expressed in sural nerve and 186 other tissues.
DR   ExpressionAtlas; Q14690; baseline and differential.
DR   Genevisible; Q14690; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032040; C:small-subunit processome; IBA:GO_Central.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; IEA:UniProtKB-KW.
DR   CDD; cd05701; S1_Rrp5_repeat_hs10; 1.
DR   CDD; cd05702; S1_Rrp5_repeat_hs11_sc8; 1.
DR   CDD; cd05703; S1_Rrp5_repeat_hs12_sc9; 1.
DR   CDD; cd05704; S1_Rrp5_repeat_hs13; 1.
DR   CDD; cd05705; S1_Rrp5_repeat_hs14; 1.
DR   CDD; cd05693; S1_Rrp5_repeat_hs1_sc1; 1.
DR   CDD; cd05694; S1_Rrp5_repeat_hs2_sc2; 1.
DR   CDD; cd05695; S1_Rrp5_repeat_hs3; 1.
DR   CDD; cd05696; S1_Rrp5_repeat_hs4; 1.
DR   CDD; cd05697; S1_Rrp5_repeat_hs5; 1.
DR   CDD; cd05698; S1_Rrp5_repeat_hs6_sc5; 1.
DR   CDD; cd05699; S1_Rrp5_repeat_hs7; 1.
DR   CDD; cd04461; S1_Rrp5_repeat_hs8_sc7; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 8.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 1.
DR   InterPro; IPR003107; HAT.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR045209; Rrp5.
DR   InterPro; IPR022967; S1_dom.
DR   InterPro; IPR003029; S1_domain.
DR   InterPro; IPR008847; Suf.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR23270; PROGRAMMED CELL DEATH PROTEIN 11 PRE-RRNA PROCESSING PROTEIN RRP5; 1.
DR   PANTHER; PTHR23270:SF10; PROTEIN RRP5 HOMOLOG; 1.
DR   Pfam; PF00575; S1; 4.
DR   Pfam; PF05843; Suf; 1.
DR   SMART; SM00386; HAT; 7.
DR   SMART; SM00316; S1; 13.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 11.
DR   SUPFAM; SSF48452; TPR-like; 2.
DR   PROSITE; PS50126; S1; 12.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; rRNA processing;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   CHAIN           2..1871
FT                   /note="Protein RRP5 homolog"
FT                   /id="PRO_0000205762"
FT   DOMAIN          83..171
FT                   /note="S1 motif 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          187..258
FT                   /note="S1 motif 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          281..346
FT                   /note="S1 motif 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          365..436
FT                   /note="S1 motif 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          453..522
FT                   /note="S1 motif 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          542..611
FT                   /note="S1 motif 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          636..707
FT                   /note="S1 motif 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          729..798
FT                   /note="S1 motif 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          1036..1109
FT                   /note="S1 motif 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          1149..1222
FT                   /note="S1 motif 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          1230..1298
FT                   /note="S1 motif 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   DOMAIN          1324..1396
FT                   /note="S1 motif 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00180"
FT   REPEAT          1599..1631
FT                   /note="HAT 1"
FT   REPEAT          1705..1737
FT                   /note="HAT 2"
FT   REPEAT          1775..1807
FT                   /note="HAT 3"
FT   REPEAT          1809..1844
FT                   /note="HAT 4"
FT   REGION          1..62
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          998..1018
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1395..1531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1549..1586
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10..24
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1414..1456
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1467..1526
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1557..1586
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         1362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         1476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NS46"
FT   MOD_RES         1493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1498
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:23186163"
FT   CROSSLNK        1030
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        1416
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         45
FT                   /note="K -> E (in dbSNP:rs150893869)"
FT                   /evidence="ECO:0000269|PubMed:26566883"
FT                   /id="VAR_076436"
FT   VARIANT         397
FT                   /note="S -> N (in dbSNP:rs7074814)"
FT                   /id="VAR_054485"
FT   VARIANT         623
FT                   /note="A -> S (in dbSNP:rs11598673)"
FT                   /id="VAR_031669"
FT   VARIANT         780
FT                   /note="A -> S (in dbSNP:rs11591914)"
FT                   /id="VAR_054486"
FT   VARIANT         1216
FT                   /note="L -> F (in dbSNP:rs2986014)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8724849"
FT                   /id="VAR_031670"
FT   VARIANT         1453
FT                   /note="P -> S (in dbSNP:rs2274289)"
FT                   /id="VAR_054487"
FT   VARIANT         1871
FT                   /note="D -> A (in dbSNP:rs7831)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_014930"
FT   CONFLICT        1431
FT                   /note="Missing (in Ref. 4; AAH49838)"
FT                   /evidence="ECO:0000305"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   STRAND          189..197
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   STRAND          199..205
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   HELIX           217..227
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   STRAND          228..230
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   STRAND          238..245
FT                   /evidence="ECO:0007829|PDB:1WI5"
FT   STRAND          252..256
FT                   /evidence="ECO:0007829|PDB:1WI5"
SQ   SEQUENCE   1871 AA;  208701 MW;  8ED3665EB503CBB0 CRC64;
     MANLEESFPR GGTRKIHKPE KAFQQSVEQD NLFDISTEEG STKRKKSQKG PAKTKKLKIE
     KRESSKSARE KFEILSVESL CEGMRILGCV KEVNELELVI SLPNGLQGFV QVTEICDAYT
     KKLNEQVTQE QPLKDLLHLP ELFSPGMLVR CVVSSLGITD RGKKSVKLSL NPKNVNRVLS
     AEALKPGMLL TGTVSSLEDH GYLVDIGVDG TRAFLPLLKA QEYIRQKNKG AKLKVGQYLN
     CIVEKVKGNG GVVSLSVGHS EVSTAIATEQ QSWNLNNLLP GLVVKAQVQK VTPFGLTLNF
     LTFFTGVVDF MHLDPKKAGT YFSNQAVRAC ILCVHPRTRV VHLSLRPIFL QPGRPLTRLS
     CQNLGAVLDD VPVQGFFKKA GATFRLKDGV LAYARLSHLS DSKNVFNPEA FKPGNTHKCR
     IIDYSQMDEL ALLSLRTSII EAQYLRYHDI EPGAVVKGTV LTIKSYGMLV KVGEQMRGLV
     PPMHLADILM KNPEKKYHIG DEVKCRVLLC DPEAKKLMMT LKKTLIESKL PVITCYADAK
     PGLQTHGFII RVKDYGCIVK FYNNVQGLVP KHELSTEYIP DPERVFYTGQ VVKVVVLNCE
     PSKERMLLSF KLSSDPEPKK EPAGHSQKKG KAINIGQLVD VKVLEKTKDG LEVAVLPHNI
     RAFLPTSHLS DHVANGPLLH HWLQAGDILH RVLCLSQSEG RVLLCRKPAL VSTVEGGQDP
     KNFSEIHPGM LLIGFVKSIK DYGVFIQFPS GLSGLAPKAI MSDKFVTSTS DHFVEGQTVA
     AKVTNVDEEK QRMLLSLRLS DCGLGDLAIT SLLLLNQCLE ELQGVRSLMS NRDSVLIQTL
     AEMTPGMFLD LVVQEVLEDG SVVFSGGPVP DLVLKASRYH RAGQEVESGQ KKKVVILNVD
     LLKLEVHVSL HQDLVNRKAR KLRKGSEHQA IVQHLEKSFA IASLVETGHL AAFSLTSHLN
     DTFRFDSEKL QVGQGVSLTL KTTEPGVTGL LLAVEGPAAK RTMRPTQKDS ETVDEDEEVD
     PALTVGTIKK HTLSIGDMVT GTVKSIKPTH VVVTLEDGII GCIHASHILD DVPEGTSPTT
     KLKVGKTVTA RVIGGRDMKT FKYLPISHPR FVRTIPELSV RPSELEDGHT ALNTHSVSPM
     EKIKQYQAGQ TVTCFLKKYN VVKKWLEVEI APDIRGRIPL LLTSLSFKVL KHPDKKFRVG
     QALRATVVGP DSSKTLLCLS LTGPHKLEEG EVAMGRVVKV TPNEGLTVSF PFGKIGTVSI
     FHMSDSYSET PLEDFVPQKV VRCYILSTAD NVLTLSLRSS RTNPETKSKV EDPEINSIQD
     IKEGQLLRGY VGSIQPHGVF FRLGPSVVGL ARYSHVSQHS PSKKALYNKH LPEGKLLTAR
     VLRLNHQKNL VELSFLPGDT GKPDVLSASL EGQLTKQEER KTEAEERDQK GEKKNQKRNE
     KKNQKGQEEV EMPSKEKQQP QKPQAQKRGG RECRESGSEQ ERVSKKPKKA GLSEEDDSLV
     DVYYREGKEE AEETNVLPKE KQTKPAEAPR LQLSSGFAWN VGLDSLTPAL PPLAESSDSE
     EDEKPHQATI KKSKKERELE KQKAEKELSR IEEALMDPGR QPESADDFDR LVLSSPNSSI
     LWLQYMAFHL QATEIEKARA VAERALKTIS FREEQEKLNV WVALLNLENM YGSQESLTKV
     FERAVQYNEP LKVFLHLADI YAKSEKFQEA GELYNRMLKR FRQEKAVWIK YGAFLLRRSQ
     AAASHRVLQR ALECLPSKEH VDVIAKFAQL EFQLGDAERA KAIFENTLST YPKRTDVWSV
     YIDMTIKHGS QKDVRDIFER VIHLSLAPKR MKFFFKRYLD YEKQHGTEKD VQAVKAKALE
     YVEAKSSVLE D
//
